v. 13 – 2020/01
|Market Executive Summary||
This is not a detailed traceability requirement, merely a national re-iteration of GDP practices;
Traceability / anti-counterfeit measures have been under discussion for a number of years but no specific requirements. Close collaboration with Argentina’s ANMAT is expected.
|Key Dates||2013: Publishing of Good Distribution and Storage practices for Pharmaceutical Distributors|